Compositions and Methods for Identification of a Duplicate Sequencing Read
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application 61/903,826, filed Nov 13, 2013. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,546,399 | Compositions and Methods for Identification of a Duplicate Sequencing Read In force · High confidence | Tecan Genomics, Inc. | In force | High confidence | ||
| US 10,570,448 | Compositions and Methods for Identification of a Duplicate Sequencing Read In force · High confidence | Tecan Genomics, Inc. | In force | High confidence | ||
| US 11,098,357 | Compositions and Methods for Identification of a Duplicate Sequencing Read In force · High confidence | Tecan Genomics, Inc. | In force | High confidence | ||
| US 11,725,241 | Compositions and Methods for Identification of a Duplicate Sequencing Read In force · High confidence | Tecan Genomics, Inc. | In force | High confidence | ||
| Application 18/341,436 | Compositions and Methods for Identification of a Duplicate Sequencing Read Pending Not granted | Tecan Genomics, Inc. | Pending | Not granted |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Tecan Genomics, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.